76126-075 : Mesna 100 mg/ml Intravenous Injection, Solution


NDC: 76126-075
Labeler: Agila Specialties Private Limited
Product Type: Human Prescription Drug
Drug Name:  Mesna
Dosage Form: Intravenous Injection, Solution
Application #: ANDA203364
Rev. Date: 


NDC Package Codes:

  • 76126-075-01: 1 VIAL, MULTI‑DOSE IN 1 CARTON (76126‑075‑01) > 10 ML IN 1 VIAL, MULTI‑DOSE

Active Ingredients:

  • Mesna

Dosage Strength:

  • 100 mg/mL

Pharmaceutical Classes:

  • Cytoprotective Agent [EPC]

Related Products:

Based on records with the same trade name.
  • 0143-9260 Mesna 100 mg/ml Intravenous Injection, Solution by Hikma Pharmaceuticals USA Inc.
  • 0703-4805 Mesna 100 mg/ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc
  • 10019-951 Mesna 100 mg/ml Intravenous Injection, Solution by Baxter Healthcare Corporation
  • 10019-953 Mesna 100 mg/ml Intravenous Injection, Solution by Baxter Healthcare Corporation
  • 25021-201 Mesna 100 mg/ml Intravenous Injection by Sagent Pharmaceuticals
  • 47781-622 Mesna 100 mg/ml Intravenous Injection, Solution by Alvogen Inc.
  • 62778-304 Mesna 100 mg/ml Intravenous Injection, Solution by Hikma Farmaceutica
  • 63323-733 Mesna 100 mg/ml Intravenous Injection, Solution by App Pharmaceuticals, LLC
  • 67457-148 Mesna 100 mg/ml Intravenous Injection, Solution by Mylan Institutional LLC
  • 68083-161 Mesna 100 mg/ml Intravenous Solution by Gland Pharma Limited
  • 70860-209 Mesna 100 mg/ml Intravenous Injection, Solution by Athenex Pharmaceutical Division, LLC.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 76126-075 QR Code

< Prev: 76126-072Next: 76126-100 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.